Biogen cuts the price tag on its Alzheimer's drug in half
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...
Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...
Biogen is slashing the price of its Alzheimer’s treatment months after the drug debuted to widespread criticism for an initial cost that can reach $56,000...
The price of Biogen Alzheimer’s disease drug Aduhelm will be cut in half at the start of 2022, a move that comes as a Medicare recommendation on coverage is expected early next year. Meanwhile, Biogen is preparing corporate measures projected to save $500 million annually, cost-cutting made necessary in part due to slow market uptake of Aduhelm.